Treatment of Vascular Dementia

Evidence based Dementia Practice

Volumn , Issue , 2008, Pages 589-607

  Kaye, Jeffrey ^a   Qizilbash, Nawab ^b,c   Lutsep, Helmi L ^d   Fioravanti, Mario ^e   Flicker, Leon ^f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Servicio de Oncologic Department   (Spain)

^c GLAXOSMITHKLINE   (United Kingdom)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84959242170     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470752340.ch35     Document Type: Chapter

References (55)

1. Agnoli, A., Fioravanti, M. & Lechner, H. (1985) Efficacy of CDP-Choline in chronic cerebral vascular diseases (CCVD). In: Novel Biochemical, Pharmacological, and Clinical Aspects of Cytidinediphosphocholine (eds V. Zappia, E.P. Kennedy, B.I. Nilsson, P.V. Galletti). Elsevier Science, New York.
2. Angeli, G. (1985) Sperimentazione clinica sul prodotto denominato provvisoriamente Asonic. Rivista di Neuropsichiatria e Scienze Affini 31, 13-24 [in Italian].
3. Antiplatelet Trialists' Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapyaI: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. British Medical Journal 308, 81-106.
4. Barbagallo-Sangiorgi, G., Ceruso, D., Cuzzupoli, M. et al. (1988) Studio multicentrico in doppio cieco con Citicolina nel deterioramento mentale senile primitivo. In: Invecchiamento Cerebrale e Cerebrovasculopatie Croniche (ed. G. Barbagallo-Sangiorgi, et al.). CIC Edizioni Internazionali, Roma [in Italian].
5. Black, R.S., Barclay, L.L., Nolan, K.A., Thaler, T.T., Hardiman, S.T. & Blass, J.P. (1992) Pentoxifylline in cerebrovascular dementia. Journal of the American Geriatrics Society 40, 237-244.
6. Blume, J., Ruhlmann, K.U., De La Hay, R. & Rettig, K. (1992) Treatment of chronic cerebrovascular disease in elderly patients with Pentoxifylline. Journal of Medicine 23 (6), 417-432.
7. Blume, J., Ruhlmann, K.U., De La Haye, R., Rettig, K. & Oltmer, G. (1990) Vascular induced disorders of cerebral performance in the elderlyalong term therapy with pentoxifylline and psychological training. Fortschritte der Therapie 108, 638-642.
8. Bonavita, E., Chioma, V., Dall'Oca, P. et al. (1983) Studio in doppio cieco sull'azione della citicolina nel cervello senile. Minerva Psichiatrica 24, 53-62 [in Italian].
9. CAPRIE Steering Committee (1996) A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 348, 1329-1339.
10. Capurso, A., Capurso, S., Panza, F. et al. (1996) Efficacy of cytidine diphosphate choline in patients affected by chronic cerebrovascular disease. Clinical Drug Invstigations 12, 26-38.
11. Chui, H.C., Victoroff, J.I., Margolin, D., Jagust, W., Shankle, R. & Katzman, R. (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42, 473-480.
12. Collins, R., Peto, R., MacMahon, S. et al. (1990) Blood pressure, stroke and coronary artery heart disease, Part II: Effects of short-term reductions in blood pressureaan overview of randomised drug trials in an epidemiological context. Lancet 335, 827-838.
13. Crepaldi, G., Rossi, A., Coscetti, G., Abbruzzese, E., Claveri, U. & Calabro, A. (1992) Sulodexide oral administration influences blood viscosity and fibrinolysis. Drugs Experimental Clinical Research 18, 189-195
14. Diener, H.C., Cunha, L., Forbes, C., Sivenius, J., Smets, P. & Lowenthal, A. (1996) European stroke prevention study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. Journal of the Neurological Sciences 143, 1-13.
15. Dominguez, D., de Cayaffa, C.L., Gomensoro, J. & Aparicio, J. (1977) Modification of psychometric, practical and intellectual parameters in patients with diffuse cerebrovascular insufficiency during prolonged treatment with pentoxifylline: a double-blind, placebo controlled trial. Pharmatherapeutica 1 (8), 498-506.
16. Erkinjuntti, T. & Hachinski, V. (1993) Rethinking vascular dementia. Cerebrovascular Disease 3, 3-23.
17. European Pentoxifylline Multi-Infarct Dementia (EPMID) Study Group (1996) European Pentoxifylline Multi- Infarct Dementia Study. European Neurology 36, 315-321.
18. Falchi Delitata, G., Falchi Delitata, N., Casali, R. et al. (1984) Intermediate term, double-blind vs. placebo study of CDP-choline in cases with cognitive senile deterioration. Gazzetta Medica ItalianabArchivio Scienze Mediche 143, 789-810.
19. Fioravanti, M. & Yanagi, M. (1999) Cytidinediphosphocholine for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly (Cochrane Review). The Cochrane Library, Issue 4, 1999. Oxford: Update Software.
20. Forette, F. & Boller, F. (1991) Hypertension and risk of dementia in the elderly. American Journal of Medicine 90, 14S-19S.
21. Forette, F., Seux, M.-L., Staessen, J.A. et al. on behalf of the Syst-Eur lnvestigators (1998) Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 352, 1347-1351.
22. Frampton, J.E. & Brogden, R.N. (1995) Pentoxifylline (Oxpentifylline) A Review of its Therapeutic Efficacy in the Management of Peripheral Vascular and Cerebrovascular Disorders. Drugs and Ageing 7 (6), 480-503.
23. Galeone, F., Nannetti, D., Giuntoli, F., Galeone, S., Gabbani, S. & Saba, P. (1988) Evaluation of the activity of sulodexide in patients with senile deterioration. Current Therapeutic Research 43, 636-642.
24. Gent, M., Blakely, J.A., Easton, J.D. et al. (1989) The Canadian American ticlopidine study (CATS) in thromboembolic stroke. Lancet I, 1215-1220.
25. Ghose, K. (1987) Oxpentifylline in dementia: a controlled study. Archives of Gerontology and Geriatrics 6 (1), 9-26.
26. Hansson, L., Lithell, H., Skoog, I. et al. (2000) Study on Cognition and Prognosis in the Elderly (SCOPE): Baseline Characteristics. Blood Pressure 9 (2-3), 146-151.
27. Harwart, D. (1979) The treatment of chronic cerebrovasular insufficiency. A double-blind study with pentoxifylline ('Trental' 400). Current Medical Research and Opinion 6 (2), 73-84.
28. Hass, W.K., Easton, J.D., Adams, H.P. et al. (1989) A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. New England Journal of Medicine 321, 501-507.
29. Hofman, A., Ott, A., Breteler, M.M.B. et al. (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementi and Alzheimer's disease in the Rotterdam study. Lancet 349, 151-154.
30. Mauro, M., Palmieri, G.C., Palazzini, D., Barbanti, M., Rindina, F.C. & Milani, M.R. (1993) Pharmacodynamic effects of single and repeated doses of oral sulodexide in healthy volunteers: a placebo-controlled study with an enteric-coated formulation. Current Medical Research and Opinion 13, 87-95.
31. Medariaga Aguirre, L.M., Espina Tamarigo, J.M., Pascual Lazaro, A., Ortiz Tripol, L.G. & Castro del Pozo, J.M. (1978) Estudio double ciego sobre un grupo de enfermas seniles tratadas con CDP-colina. Revista de Psiquiatria Y Psicologia Medica 13, 331-342 [in Spanish].
32. Meyer, J.S., Rogers, R.L., McClintic, K., Mortel, K.F. & Lotfi, J. (1989) Randomized clinical trial of daily aspirin therapy in multi-infarct dementia: a pilot study. Journal of the American Geriatrics Society 37, 549-555.
33. Moroney, J.T., Tseng, C.-L., Paik, M.C., Mohr, J.P. & Desmond, D.W. (1999) Treatment for the secondary prevention of stroke in older patients: the influence of dementia status. Journal of the American Geriatrics Society 47, 824-829.
34. Motta, L., Fichera, G., Tiralosi, G. & Di Stefano, A. La citicolina nel trattamento delle cerebrovasculopatie croniche. Unpublished Lederle (Cyanamid Italia) report [in Italian].
35. Parnetti, L., Ciuffetti, G., Mercuri, M. & Senin, U. (1985) Haemorheological pattern in initial mental deterioration: results of a long-term study using piracetam and pentoxifylline. Archives of Gerontology and Geriatrics 4, 141-155.
36. Parnetti, L., Ciuffetti, G., Mercuri, M., Lupattelli, G. & Senin, U. (1986) The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration. Pharmatherapeutica 4 (10), 617-627.
37. Parnetti, L., Mari, D., Abate, G. et al. (1997) Vascular dementia Italian sulodexide study (VA.D.I.S.S.): clinical and biological results. Thrombosis Research 87, 225-233.
38. Piccoli, F., Battistini, N., Carbonin, P. et al. (1994) CDP-choline in the treatment of chronic cerebrovasculopathies. Archives of Gerontology and Geriatrics 18, 161-168.
39. Prince, M.J., Bird, A.S., Blizard, R.A. & Mann, A.H. (1996) Is cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults British Medical Journal 312, 801-805.
40. Prospective Studies Collaboration (1995) Cholesterol, blood pressure and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 346, 1647-1653.
41. Qizilbash, N. & Evans, J.G. (2000) Prevention of stroke. In: Oxford Textbook of Geriatric Medicine, 2nd edn (eds Evans, J.G., Williams, F.T., Beattie, B.L., Miechel, J.P. & Wilcock, G.K.) 2nd edn. pp. 455-462. Oxford University Press, Oxford.
42. Richards, M., Meade, T.W., Peart, S., Brennan, P.J. & Mann, A.H. (1997) Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings. Journal of Neurology, Neurosurgery, and Psychiatry 62, 269-272.
43. Rockwood, K., Bowler, J., Erkinjuntti, T., Hachinski, V. & Wallin, A. (1999) Subtypes of vascular dementia. Alzheimer's Disease and Associated Disorders 13 (Suppl. 3): S59-S65.
44. Rockwood, K., Ebly, E., Hachinski, V. & Hogan, D. (1997) Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Archives of Neurology 54, 33-39.
45. Roman, G.C., Tatemichi, T.K., Erkinjuntti, T. et al. (1993) Vascular Dementia. Diagnostic Criteria for Research Studies. Report of the NINDS-AIREN International Work Group. Neurology 43, 250-260.
46. Schneider, L.S. & Olin, J.T. (1994) Quantitative overview of the efficacy of Hydergine. Archives of Neurology 51, 787-798.
47. Secodes, J.J. & Frontera, G. (1995) CDP-choline: pharmachological and clinical review. Methods and Findings in Experimental and Clinical Pharmacology 17 (Suppl. B), 2-54.
48. Sinforiani, E., Trucco, M., Pacchetti, C. & Gualtieri, S. (1986) Valutazione degli effetti della citicolina nella malattia cerebro-vascolare cronica. Minerva Medica 77, 51-57 [in Italian].
49. Skoog, I. (1998) Status of risk factors for vascular dementia. Neuroepidemiology 17, 2-9.
50. Spiers, P.A., Myers, D., Gail, S., Hochanadel, G.S., Lieberman, H.R. & Wurtman, R.J. (1996) Citicoline improves verbal memory in aging. Archives of Neurology 53, 441-448.
51. Sturmer, T., Glynn, R.J., Field, T.S., Taylor, J.O. & Hennekens, C.H. (1996) Aspirin use and cognitive function in the elderly. American Journal of Epidemology 143, 683-691.
52. SHEP Cooperative Research Group (1991) Prevention of stroke by hypertension: final results of the Systolic Hypertension in the Elderly hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). Journal of the American Medical Association 265, 3255-3264.
53. The Dutch TIA Trial Study Group (1991) A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. New England Journal of Medicine 325, 1261-1266.
54. Weiss, G.B. (1995) Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Science 56, 637-660.
55. Whitlock, G., MacMahon, S., Anderson, C. et al. (1997) Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease. PROGRESS Management Committee. Perindopril Protection Against Recurrent Stroke Study. Clinical Experimental Hypertension 19 (5-6), 843-855.